# Dexmedetomidine in Transversus Abdominis Plane Block for Laparoscopic Cholecystectomy

> **NCT02031510** · PHASE1,PHASE2 · COMPLETED · sponsor: **Imam Abdulrahman Bin Faisal University** · enrollment: 195 (actual)

## Conditions studied

- Elective Laparoscopic Cholecystectomy

## Interventions

- **DRUG:** placebo
- **DRUG:** bupivacaine
- **DRUG:** bupivacaine-dexmedetomidine

## Key facts

- **NCT ID:** NCT02031510
- **Lead sponsor:** Imam Abdulrahman Bin Faisal University
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-01
- **Primary completion:** 2015-02
- **Final completion:** 2015-03
- **Target enrollment:** 195 (ACTUAL)
- **Last updated:** 2015-04-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02031510

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02031510, "Dexmedetomidine in Transversus Abdominis Plane Block for Laparoscopic Cholecystectomy". Retrieved via AI Analytics 2026-07-16 from https://api.ai-analytics.org/clinical/NCT02031510. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*